迈博药业有限公司（02181）于2025年12月3日向香港联合交易所有限公司提交的最新月报表显示，截至2025年11月30日，公司注册股本及已发行股份总数均与上月保持一致，未发生新增发行、购回、注销或库藏股份等变动。
公司公告显示，迈博药业注册股本为50,000,000,000股普通股，面值每股0.0001美元，注册资本总额续维持5,000,000美元不变；已发行股本为4,124,080,000股普通股，无任何购回或新增发行活动。报告期内，公司持有的期权数量为72,670,876份，与上月一致。
公告同时确认，截至本月末，公司股本及股权结构保持稳定。公司续表示将遵守香港联交所《上市规则》及相关法律的规定。
该公告由公司秘书曾浩贤先生签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.